Hari Pujar
Operationeel Directeur bij Tessera Therapeutics, Inc.
Profiel
Hari Pujar is currently the Chief Operating Officer at Tessera Therapeutics, Inc. Previously, he worked as the Chief Technology Officer at Spark Therapeutics, Inc. He holds an MBA from the University of Pennsylvania and a doctorate from the University of Delaware.
Actieve functies van Hari Pujar
| Bedrijven | Functie | Begin |
|---|---|---|
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Operationeel Directeur | 07-04-2021 |
Eerdere bekende functies van Hari Pujar
| Bedrijven | Functie | Einde |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Hari Pujar
| University of Delaware | Doctorate Degree |
| University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Health Technology |
